Radiance completes brachytherapy trial enrolment:
This article was originally published in Clinica
Radiance Medical Systems has completed the enrolment phase of its pivotal intracoronary radiation therapy trial. The BRITE II study is assessing the firm's RDX coronary radiation delivery system as a treatment for in-stent restenosis. Some 423 patients from 26 sites in the US and Europe have received the treatment and will now be followed-up for nine months. The Irvine, California firm plans to use data generated from the study to support a marketing application for the product in the US.